Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,811,036
-$503,217 QoQ
Shares Held
537,061
-23.3% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Derivatives in KALV
reported options exposure · as of Jun 30, 2025CallValue
$574,294
CallShares
50,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. KALV ranks #25 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in KALV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,811,036 | 537,061 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,314,253 | 700,573 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,038,870 | 577,904 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $574,294 | 50,800 | Call | Sole | 2026-02-27 | |
| 2025-06-30 | $1,909,673 | 168,923 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $637,319 | 55,227 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $576,485 | 68,062 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $778,430 | 67,222 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $152,727 | 12,965 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $260,386 | 21,955 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $521,004 | 42,531 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $40,590 | 4,215 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $44,154 | 4,906 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $97,565 | 12,413 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $44,426 | 6,572 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $38,436 | 2,649 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $19,384 | 1,970 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $53,624 | 3,638 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $383,483 | 28,986 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $181,549 | 10,404 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $121,452 | 5,069 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $855,038 | 33,283 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $259,782 | 13,680 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $184,544 | 14,658 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $169,411 | 14,001 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $81,693 | 10,679 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||